Fig 1.
Study flowchart.
Table 1.
Baseline characteristics of study population.
Table 2.
Clinical outcomes of study population.
Fig 2.
Adjusted odds of adverse events in the hybrid therapy group.
aReference group is Concomitant therapy group.
Table 3.
Analysis of all adverse events of the study populationc.
Table 4.
Analysis of adverse event severity.